Thomas Schaser

560 total citations
15 papers, 412 citations indexed

About

Thomas Schaser is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Thomas Schaser has authored 15 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Genetics. Recurrent topics in Thomas Schaser's work include Virus-based gene therapy research (11 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Thomas Schaser is often cited by papers focused on Virus-based gene therapy research (11 papers), CAR-T cell therapy research (11 papers) and Viral Infectious Diseases and Gene Expression in Insects (9 papers). Thomas Schaser collaborates with scholars based in Germany, Switzerland and Netherlands. Thomas Schaser's co-authors include Christian J. Buchholz, Klaus Cichutek, Michael D. Mühlebach, Andrew Kaiser, Dominik Lock, Robert C. Münch, Sabrina Kneissl, Ian Johnston, Andreas Plückthun and Christian Jöst and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Frontiers in Immunology.

In The Last Decade

Thomas Schaser

14 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Schaser Germany	10	275	228	206	90	71	15	412
Savan K. Patel United States	5	144 0.5×	304 1.3×	87 0.4×	88 1.0×	87 1.2×	5	418
Hugo Calderón Spain	7	388 1.4×	199 0.9×	197 1.0×	103 1.1×	179 2.5×	13	524
Megha Shettigar United States	3	355 1.3×	174 0.8×	325 1.6×	47 0.5×	196 2.8×	3	533
Vincent Allain France	9	231 0.8×	179 0.8×	99 0.5×	52 0.6×	81 1.1×	22	388
Sabrina Kneissl Germany	8	136 0.5×	239 1.0×	269 1.3×	21 0.2×	31 0.4×	8	370
Mario Bunse Germany	11	301 1.1×	225 1.0×	160 0.8×	50 0.6×	288 4.1×	17	560
Suvi Sorsa Finland	13	623 2.3×	239 1.0×	486 2.4×	47 0.5×	220 3.1×	22	725
Caroline E. Porter United States	6	340 1.2×	145 0.6×	236 1.1×	65 0.7×	92 1.3×	13	375
Elham Fakhr Germany	7	117 0.4×	212 0.9×	53 0.3×	43 0.5×	79 1.1×	9	329
Chris Twitty United States	12	330 1.2×	258 1.1×	126 0.6×	33 0.4×	391 5.5×	18	654

Countries citing papers authored by Thomas Schaser

Since Specialization

Citations

This map shows the geographic impact of Thomas Schaser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schaser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schaser more than expected).

Fields of papers citing papers by Thomas Schaser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schaser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schaser. The network helps show where Thomas Schaser may publish in the future.

Co-authorship network of co-authors of Thomas Schaser

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schaser. A scholar is included among the top collaborators of Thomas Schaser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schaser. Thomas Schaser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lock, Dominik, Boris Engels, Mario Assenmacher, et al.. (2025). A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo. Molecular Therapy — Methods & Clinical Development. 33(3). 101526–101526.

Hageman, Lois, Marieke Griffioen, Nadine Mockel-Tenbrinck, et al.. (2024). Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy. Molecular Therapy — Methods & Clinical Development. 32(2). 101224–101224. 2 indexed citations

Engels, Boris, et al.. (2024). CAR’TCR-T cells co-expressing CD33-CAR and dNPM1-TCR as superior dual-targeting approach for AML treatment. SHILAP Revista de lepidopterología. 32(2). 200797–200797. 13 indexed citations

Kaiser, Andrew, et al.. (2023). Combining CSPG4-CAR and CD20-CCR for treatment of metastatic melanoma. Frontiers in Immunology. 14. 1178060–1178060. 5 indexed citations

Thalheimer, Frederic B., et al.. (2023). CD62L as target receptor for specific gene delivery into less differentiated human T lymphocytes. Frontiers in Immunology. 14. 1183698–1183698. 6 indexed citations

Lock, Dominik, Razieh Monjezi, Marco Schmeer, et al.. (2022). Automated, scaled, transposon-based production of CAR T cells. Journal for ImmunoTherapy of Cancer. 10(9). e005189–e005189. 33 indexed citations

Assenmacher, Mario, et al.. (2022). Adapter-Mediated Transduction with Lentiviral Vectors: A Novel Tool for Cell-Type-Specific Gene Transfer. Viruses. 14(10). 2157–2157. 5 indexed citations

Lock, Dominik, Franziska Blaeschke, Sandra Karitzky, et al.. (2021). Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells. Molecular Therapy — Methods & Clinical Development. 21. 42–53. 10 indexed citations

Alzubi, Jamal, Dominik Lock, Manuel Rhiel, et al.. (2020). Automated generation of gene-edited CAR T cells at clinical scale. Molecular Therapy — Methods & Clinical Development. 20. 379–388. 41 indexed citations

10.

Gutiérrez-Guerrero, Alejandra, François–Loïc Cosset, Andrew Kaiser, et al.. (2019). Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing. Human Gene Therapy. 30(12). 1477–1493. 30 indexed citations

11.

Schaser, Thomas, et al.. (2019). Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors. Molecular Therapy — Methods & Clinical Development. 13. 371–379. 50 indexed citations

12.

Lock, Dominik, Nadine Mockel-Tenbrinck, Daniela Mauer, et al.. (2017). Automated Manufacturing of Potent CD20-Directed Chimeric Antigen Receptor T Cells for Clinical Use. Human Gene Therapy. 28(10). 914–925. 85 indexed citations

13.

Münch, Robert C., Michael D. Mühlebach, Thomas Schaser, et al.. (2011). DARPins: An Efficient Targeting Domain for Lentiviral Vectors. Molecular Therapy. 19(4). 686–693. 91 indexed citations

14.

Schaser, Thomas, Christoph Wrede, Katja Sliva, et al.. (2011). RNAi-mediated gene silencing in tumour tissue using replication-competent retroviral vectors. Gene Therapy. 18(10). 953–960. 9 indexed citations

15.

Mühlebach, Michael D., Thomas Schaser, Martina Zimmermann, et al.. (2010). Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase–Activatable Oncolytic Measles Virus. Cancer Research. 70(19). 7620–7629. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact